Douglas Hanahan
- Cancer Research top 0.01%
- Cancer, Hypoxia, and Metabolism 22
- Protease and Inhibitor Mechanisms 20
- Oncology top 0.01%
- Pancreatic and Hepatic Oncology Research 25
- Cancer-related Molecular Pathways 19
- Molecular Biology top 0.01%
- Angiogenesis and VEGF in Cancer 31
- Immunology top 0.02%
- Immunology and Allergy top 0.02%
-
- Pancreatic function and diabetes 49
-
- Virus-based gene therapy research 29
-
- Neuroendocrine Tumor Research Advances 25
- Co-authors
- Robert A. WeinbergJudah FolkmanGabriele BergersLisa M. CoussensZena WerbOriol CasanovasMatthew MeselsonNicole Meyer-Morse
- Journals
- Proceedings of the National Academy of Sciences (21 papers)Cancer Cell (19 papers)Cell (13 papers)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Douglas Hanahan
226 papers receiving 134.0k citations
Hit Papers
Peers
Comparison fields: 5 of 209
- Cancer Research 36.5k
- Oncology 43.8k
- Molecular Biology 79.7k
- Immunology 19.2k
- Immunology and Allergy 5.0k
Countries citing papers authored by Douglas Hanahan
This map shows the geographic impact of Douglas Hanahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Hanahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Hanahan more than expected).
Fields of papers citing papers by Douglas Hanahan
This network shows the impact of papers produced by Douglas Hanahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Hanahan. The network helps show where Douglas Hanahan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas Hanahan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 33 | |
| 4 | 2023 | 42 | |
| 5 | 2021 | 29 | |
| 6 | 2019 | 28 | |
| 7 | 2018 | 30 | |
| 8 | Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formationbreakdown → | 2017 | 589 |
| 9 | 2017 | 190 | |
| 10 | Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancerbreakdown → | 2015 | 381 |
| 11 | 2015 | 139 | |
| 12 | 2013 | 52 | |
| 13 | 2011 | 114 | |
| 14 | 2010 | 18 | |
| 15 | 2006 | 60 | |
| 16 | 2004 | 22 | |
| 17 | 2004 | 86 | |
| 18 | Cross-species comparison of angiogenesis during the premalignant stages of squamous carcinogenesis in the human cervix and K14-HPV16 transgenic mice. | 1997 | 108 |
| 19 | Basic and clinical research on angiogenesis | 1996 | 1 |
| 20 | 1987 | 15 |
About Douglas Hanahan
Douglas Hanahan is a scholar working on Cancer Research, Oncology and Immunology and Allergy, having authored 230 papers that have together received 137.2k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (49 papers), Angiogenesis and VEGF in Cancer (31 papers), Virus-based gene therapy research (29 papers), Pancreatic and Hepatic Oncology Research (25 papers), Neuroendocrine Tumor Research Advances (25 papers), Cancer, Hypoxia, and Metabolism (22 papers), Protease and Inhibitor Mechanisms (20 papers) and Cancer-related Molecular Pathways (19 papers). The work is most often cited by research in Cancer Research (36.5k citations), Oncology (43.8k citations) and Molecular Biology (79.7k citations). Douglas Hanahan has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Robert A. Weinberg, Judah Folkman, Gabriele Bergers, Lisa M. Coussens, Zena Werb, Oriol Casanovas, Matthew Meselson, Nicole Meyer-Morse, Peter Olson and J Folkman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Cancer Cell, Cell, Molecular and Cellular Biology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.